Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.
作者信息
Schütz-Fuhrmann I, Castañeda J, Reznik Y, Aronson R, Conget I, Liabat S, Runzis S, de Portu S, Cohen O
机构信息
Department of Endocrinology, City Hospital Hietzing, Vienna, Austria.
Medtronic Bakken Research Center, Maastricht, The Netherlands.
出版信息
Diabet Med. 2017 Feb;34(2):291-292. doi: 10.1111/dme.13279.
PMID:27770589
Abstract
摘要
Zotero 插件